Arkolith/Insider Trading/PRQR/Form 4

de Boer Daniel Anton

Chief Executive Officer, DirectorProQR Therapeutics N.V. (PRQR) · full profile →Form 4 · filed Jul 8, 2026
Net Buying
Open-Market Buys
$239K
Open-Market Sells
$0
Net Open-Market Flow
$239K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Buy(P)150K$1.59$239K150K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-081762) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML